U.S. Patient Assistance Programs

U.S. Patient Assistance Programs

We believe that no one should go without the medicines or adult vaccines they need.

Consequently, our company provides our medicines and adult vaccines free to people who do not have prescription drug or health insurance coverage and who, without our assistance, could not afford these medicines and vaccines. This approach is consistent with our company’s long-held values and tradition of putting patients first.

More than 56 years ago, our company created our first U.S. patient assistance program (PAP) to keep affordable medicines within patients’ reach. Through these programs, we have provided more than 37.3 million free prescriptions and adult vaccines, representing a total value (at wholesale acquisition cost) of more than $4.89 billion.

Learn more about our U.S. patient assistance programs, including eligibility requirements.

COMMUNICATING OUR PROGRAMS TO DOCTORS & CONSUMERS

We work to raise awareness of our patient assistance programs among doctors and eligible patients via brochures and via enrollment forms posted on our website and other company communications, including social media. All toll-free phone lines for our medicines and/or vaccines include an option for patients to learn about our patient assistance programs.

PARTNERSHIP FOR PRESCRIPTION ASSISTANCE

We also participate in the Partnership for Prescription Assistance (PPA), a pharmaceutical industry initiative. The initiative brings together America’s pharmaceutical companies, as well as doctors, patient advocacy organizations and civic groups, to help low-income, uninsured patients get free or nearly free brand-name medicines. PPA does this through a single website that provides information for and access to more than 475 public and private patient assistance programs, including approximately 200 programs offered by biopharmaceutical companies. To date, PPA has helped millions of Americans get free or reduced-cost prescription medicines.

Our participation in PPA underscores our commitment to helping low-income, uninsured patients gain access to our medicines and adult vaccines. Learn more about the Partnership for Prescription Assistance.

Performance

PATIENT ASSISTANCE PROGRAMS SUMMARY

20122013201420152016
Patients utilizing our U.S. Patient Assistance Program1 (thousands)444400301293306
30-day prescriptions filled (millions)2.21.21.61.61.7
Total value of our company's medicines dispensed under our U.S. Patient Assistance Program (in millions)2$559.00$566.40$432.90$566.60$798.27
1. Totals represent 2012 to 2016 volumes of our U.S. Patient Assistance Program. 
2. Totals are based on the U.S. wholesale acquisition cost (WAC) and cover all programs.

Changes within the patient and prescription volumes for 2013–2016 are a result of periodic changes in the products covered in the U.S. Patient Assistance Program. Product changes are due, in part, to the inclusion of new products, and as a result from company divestitures, introductions of competing products, and the availability of generic alternatives.